Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124886) titled 'Construction of a Multi-Omics-Based Biobank for Inflammatory Bowel Disease and Investigation of Mechanisms Underlying Differential Responses to Biologics and Targeted Therapies' on May 19.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Hangzhou First People's Hospital
Condition:
Inflammatory bowel disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-19
Target Sample Size: Observation group of response and non-response to biological agents/targeted drugs:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...